Publication | Closed Access

Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result

Adefovir Combination TherapyHepatologyViral HepatitisAntiviral Drug DevelopmentHepatitis BHepatitisVirologyAntiviral TherapyHigh Viral LoadEntecavir MonotherapyChronic Viral InfectionAntiviral DrugMedicine